General Information of the Compound
Compound ID
CP0403559
Compound Name
N-[2-[[6-[(4-fluorophenyl)methyl]-2-pyridin-2-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]ethyl]acetamide
    Show/Hide
Structure
Formula
C23H25FN6O
Molecular Weight
420.492
Canonical SMILES
CC(=O)NCCNc1nc(nc2CCN(Cc3ccc(F)cc3)Cc12)-c1ccccn1
    Show/Hide
InChI
InChI=1S/C23H25FN6O/c1-16(31)25-11-12-27-22-19-15-30(14-17-5-7-18(24)8-6-17)13-9-20(19)28-23(29-22)21-4-2-3-10-26-21/h2-8,10H,9,11-15H2,1H3,(H,25,31)(H,27,28,29)
    Show/Hide
InChIKey
UDIXBLYBCJKBOV-UHFFFAOYSA-N
Physicochemical Property
logP
2.784
Rotatable Bonds
7
Heavy Atom Count
31
Polar Areas
83.04
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127042857
ChEMBL ID
CHEMBL3745927
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000259 FRT Rattus norvegicus (Rat)  1
1
EC50 = 200 nM
   TI
   LI
   LO
   TS
CL000068 A-549 Homo sapiens (Human)  1
1
EC50 = 400 nM
   TI
   LI
   LO
   TS